Providing hepatitis C treatment in jails

Implementing a Low-Threshold Hepatitis C Treatment in a Jail Setting

NIH-funded research Rhode Island Hospital · NIH-11007380

This study is looking at a new way to help people in jail who have hepatitis C, especially those who also have HIV, by giving them easy access to treatment and support so they can manage their health while they're incarcerated and after they get out.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionRhode Island Hospital NIH-funded
Lab location1 site (Providence, United States)
Project IDNIH-11007380 on NIH RePORTER

What this research studies

This research aims to implement a low-threshold treatment approach for hepatitis C virus (HCV) in jail settings, targeting individuals who inject drugs. By utilizing a modified treatment protocol called MINMON-J, the project will provide take-home medications and support from community health workers to help patients navigate care both during and after incarceration. The study will evaluate how effective and feasible this approach is for treating HCV among jailed individuals, particularly those with co-infection of HIV.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who inject drugs and are currently incarcerated with hepatitis C, either alone or in combination with HIV.

Not a fit: Patients who are not incarcerated or those who do not have hepatitis C or HIV may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could significantly improve access to hepatitis C treatment for incarcerated individuals, leading to better health outcomes.

How similar studies have performed: Previous research has shown success with low-barrier treatment models for hepatitis C in other settings, indicating potential for this approach in jails.

Where this research is happening

Providence, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.